Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction

被引:40
作者
Dalen, Magnus [1 ,2 ]
Lund, Lars H. [3 ,4 ]
Ivert, Torbjorn [1 ,2 ]
Holzmann, Martin J. [4 ,5 ]
Sartipy, Ulrik [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
[4] Karolinska Inst, Dept Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
LONG-TERM SURVIVAL; CARDIAC-SURGERY; OUTCOMES; RISK; DYSFUNCTION; REGISTRY; DISEASE; ASSOCIATION; PREVALENCE; VALIDATION;
D O I
10.1001/jamacardio.2016.1465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Data on the prognostic consequence of heart failure (HF) with preserved ejection fraction in patients undergoing coronary artery bypass grafting (CABG) are limited and inconclusive. OBJECTIVE To investigate the survival after CABG in patients with preoperative HF and preserved ejection fraction (pEF) vs reduced ejection fraction (rEF). DESIGN, SETTING, AND PARTICIPANTS Swedish nationwide population-based cohort study that included all patients who underwent primary isolated CABG between January 1, 2001, and December 31, 2013, from the SwedishWeb-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) register, with follow-up for all-cause mortality in March 2014. Information regarding baseline characteristics, all-cause mortality, and readmissions for HF was obtained from national health data registers. Preserved EF was defined as at least 50%. MAIN OUTCOMES AND MEASURES The primary outcomewas all-cause mortality. A secondary outcome measure was a combination of all-cause mortality and readmission for HF. RESULTS The study included 41 906 patients, 37 234 without known HF (27 165 with pEF and 10 069 with rEF) and 4672 with HF (1216 with pEF and 3456 with rEF). Their mean (SD) age was 67.4 (9.3) years, and 21.0% were female. During a mean (SD) follow-up time of 6.0 (3.3) years, 19.0%(7943 of 41 906) of patients died, including 13.2%(3574 of 27 165) with no HF and pEF, 24.6%(2476 of 10 069) with no HF and rEF, 33.9% (412 of 1216) with HFpEF, and 42.9%(1481 of 3456) with HFrEF. The multivariable-adjusted hazard ratios for death were 1.47 (95% CI, 1.40-1.56), 1.62 (95% CI, 1.46-1.80), and 2.29 (95% CI, 2.14-2.44) in patients with no HF and rEF, patients with HFpEF, and patients with HFrEF compared with patients with no HF and pEF. The findings were similar for the combined outcome of all-cause mortality and readmission for HF. The multivariable-adjusted hazard ratios for death within 30 days of surgery were 2.25 (95% CI, 1.86-2.73), 1.83 (95% CI, 1.26-2.66), and 2.52 (95% CI, 1.99-3.19) in patients with no HF and rEF, patients with HFpEF, and patients with HFrEF. CONCLUSIONS AND RELEVANCE A history of HF was an important risk factor for poor short-term and long-term outcomes after CABG regardless of preoperative EF. Reduced EF more than doubled the risk of early death after CABG.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 50 条
  • [31] What are the Implications of Coronary Artery Disease in Patients With Heart Failure and Preserved Ejection Fraction?
    Hwang, Seok-Jae
    Melenovsky, Vojtech
    Borlaug, Barry A.
    CIRCULATION, 2013, 128 (22)
  • [32] Effects of different surgical strategies and left ventricular remodelling on the outcomes of coronary artery bypass grafting in heart failure patients with reduced ejection fraction
    Cao, Jian
    Yu, Miao
    Xiao, Yu
    Dong, Ran
    Wang, Jiayang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [33] Curative effect analysis of urapidil on heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
    Yuan, Xiao-Ye
    Ding, Cun-Tao
    Li, Jing
    Tan, Jing
    Wang, Yan-Ling
    Fan, Zhen-Xing
    He, Jing-Yu
    Yang, Wei
    Hua, Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 494 - 503
  • [34] Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction A Global Perspective
    Bistola, Vasiliki
    Farmakis, Dimitrios
    Tromp, Jasper
    Tay, Wan Ting
    Ouwerkerk, Wouter
    Angermann, Christiane E.
    Cleland, John G. F.
    Dahlstrom, Ulf
    Dickstein, Kenneth
    Ertl, Georg
    Hassanein, Mahmoud
    Liori, Sotiria
    Nikolopoulos, Petros
    Perrone, Sergio V.
    Ghadanfar, Mathieu
    Schweizer, Anja
    Obergfell, Achim
    Collins, Sean P.
    Lam, Carolyn S. P.
    Filippatos, Gerasimos
    JACC-HEART FAILURE, 2025, 13 (02) : 229 - 247
  • [35] Long Term Prognosis of Chronic Heart Failure - Reduced vs Preserved Left Ventricular Ejection Fraction
    Miyagishima, Kenji
    Hiramitsu, Shinya
    Kimura, Hisashi
    Mori, Kazumasa
    Ueda, Tomoya
    Kato, Shigeru
    Kato, Yasuchika
    Ishikawa, Shiho
    Iwase, Masatsugu
    Morimoto, Shin-ichiro
    Hishida, Hitoshi
    Ozaki, Yikio
    CIRCULATION JOURNAL, 2009, 73 (01) : 92 - 99
  • [36] Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
    Luo, Nancy
    O'Connor, Christopher M.
    Chiswell, Karen
    Anstrom, Kevin J.
    Newby, L. Kristin
    Mentz, Robert J.
    CJC OPEN, 2021, 3 (11) : 1333 - 1340
  • [37] Diagnosis of heart failure with preserved or reduced ejection fraction in a one-stop clinic
    Andrea, Rut
    Falces, Carlos
    Sanchis, Laura
    Sitges, Marta
    Heras, Magda
    Brugada, Josep
    ATENCION PRIMARIA, 2013, 45 (04): : 184 - 192
  • [38] Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction A Nationwide Cohort Study
    Vedin, Ola
    Lam, Carolyn S. P.
    Koh, Angela S.
    Benson, Lina
    Teng, Tiew Hwa Katherine
    Tay, Wan Ting
    Braun, Oscar O.
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Lund, Lars H.
    CIRCULATION-HEART FAILURE, 2017, 10 (06)
  • [39] Total arterial coronary artery bypass grafting in patients with preoperative anemia
    Spadaccio, Cristiano
    Nenna, Antonio
    Candura, Dario
    Rose, David
    Moscarelli, Marco
    Al-Attar, Nawwar
    Sutherland, Fraser
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (06) : 1528 - 1536
  • [40] Differences in Biomarkers in Patients With Heart Failure With a Reduced vs a Preserved Left Ventricular Ejection Fraction
    de Denus, Simon
    Lavoie, Joel
    Ducharme, Anique
    O'Meara, Eileen
    Racine, Normand
    Sirois, Martin G.
    Neagoe, Paul-Eduard
    Zhu, Li
    Rouleau, Jean-Lucien
    White, Michel
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (01) : 62 - 68